Evidence map›Paper›PMID 26246575›Full record

ArticleJournal of virology2015

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.

Pierre Falson, Birke Bartosch, Khaled Alsaleh, Birke Andrea Tews, Antoine Loquet, Yann Ciczora, Laura Riva, Cédric Montigny, Claire Montpellier, Gilles Duverlie and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Pierre FalsonBases Moléculaires et Structurales des Systèmes Infectieux, Institut de Biologie et Chimie des Protéines, UMR 5086, CNRS, LabEx Ecofect, University of Lyon, Lyon, France.
Birke BartoschCIRI-International Center for Infectiology Research, INSERM U1111, Ecole Normale Supérieure, CNRS UMR 5308, LabEx Ecofect, University of Lyon, Lyon, France.
Khaled AlsalehCenter for Infection and Immunity of Lille, CNRS UMR 8204, INSERM U1019, Institut Pasteur de Lille, University of Lille, Lille, France.
Birke Andrea TewsCenter for Infection and Immunity of Lille, CNRS UMR 8204, INSERM U1019, Institut Pasteur de Lille, University of Lille, Lille, France.
Antoine LoquetBases Moléculaires et Structurales des Systèmes Infectieux, Institut de Biologie et Chimie des Protéines, UMR 5086, CNRS, LabEx Ecofect, University of Lyon, Lyon, France.
Yann CiczoraCenter for Infection and Immunity of Lille, CNRS UMR 8204, INSERM U1019, Institut Pasteur de Lille, University of Lille, Lille, France.
Laura RivaCenter for Infection and Immunity of Lille, CNRS UMR 8204, INSERM U1019, Institut Pasteur de Lille, University of Lille, Lille, France.
Cédric MontignyLaboratoire des Protéines et Systèmes Membranaires, UMR 9198, Institut de Biologie Intégrative de la Cellule (I2BC), CEA, CNRS and Université Paris-Sud, CEA Saclay, Gif-sur-Yvette, France.
Claire MontpellierCenter for Infection and Immunity of Lille, CNRS UMR 8204, INSERM U1019, Institut Pasteur de Lille, University of Lille, Lille, France.
Gilles DuverlieLaboratoire de Virologie EA4294, Centre Hospitalier Universitaire d'Amiens, Université de Picardie, Amiens, France.
Eve-Isabelle PécheurBases Moléculaires et Structurales des Systèmes Infectieux, Institut de Biologie et Chimie des Protéines, UMR 5086, CNRS, LabEx Ecofect, University of Lyon, Lyon, France.
Marc le MaireLaboratoire des Protéines et Systèmes Membranaires, UMR 9198, Institut de Biologie Intégrative de la Cellule (I2BC), CEA, CNRS and Université Paris-Sud, CEA Saclay, Gif-sur-Yvette, France.
François-Loïc CossetCIRI-International Center for Infectiology Research, INSERM U1111, Ecole Normale Supérieure, CNRS UMR 5308, LabEx Ecofect, University of Lyon, Lyon, France.
Jean DubuissonCenter for Infection and Immunity of Lille, CNRS UMR 8204, INSERM U1019, Institut Pasteur de Lille, University of Lille, Lille, France jean.dubuisson@ibl.cnrs.fr f.penin@ibcp.fr.
François PeninBases Moléculaires et Structurales des Systèmes Infectieux, Institut de Biologie et Chimie des Protéines, UMR 5086, CNRS, LabEx Ecofect, University of Lyon, Lyon, France jean.dubuisson@ibl.cnrs.fr f.penin@ibcp.fr.
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris-Sud · FRCentre Hospitalier Universitaire Amiens-Picardie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledIn hepatitis C virus (HCV)-infected cells, the envelope glycoproteins E1 and E2 assemble as a heterodimer. To investigate potential changes in the oligomerization of virion-associated envelope proteins, we performed SDS-PAGE under reducing conditions but without thermal denaturation. This revealed the presence of SDS-resistant trimers of E1 in the context of cell-cultured HCV (HCVcc) as well as in the context of HCV pseudoparticles (HCVpp). The formation of E1 trimers was found to depend on the coexpression of E2. To further understand the origin of E1 trimer formation, we coexpressed in bacteria the transmembrane (TM) domains of E1 (TME1) and E2 (TME2) fused to reporter proteins and analyzed the fusion proteins by SDS-PAGE and Western blotting. As expected for strongly interacting TM domains, TME1-TME2 heterodimers resistant to SDS were observed. These analyses also revealed homodimers and homotrimers of TME1, indicating that such complexes are stable species. The N-terminal segment of TME1 exhibits a highly conserved GxxxG sequence, a motif that is well documented to be involved in intramembrane protein-protein interactions. Single or double mutations of the glycine residues (Gly354 and Gly358) in this motif markedly decreased or abrogated the formation of TME1 homotrimers in bacteria, as well as homotrimers of E1 in both HCVpp and HCVcc systems. A concomitant loss of infectivity was observed, indicating that the trimeric form of E1 is essential for virus infectivity. Taken together, these results indicate that E1E2 heterodimers form trimers on HCV particles, and they support the hypothesis that E1 could be a fusion protein. IMPORTANCE: HCV glycoproteins E1 and E2 play an essential role in virus entry into liver cells as well as in virion morphogenesis. In infected cells, these two proteins form a complex in which E2 interacts with cellular receptors, whereas the function of E1 remains poorly understood. However, recent structural data suggest that E1 could be the protein responsible for the process of fusion between viral and cellular membranes. Here we investigated the oligomeric state of HCV envelope glycoproteins. We demonstrate that E1 forms functional trimers after virion assembly and that in addition to the requirement for E2, a determinant for this oligomerization is present in a conserved GxxxG motif located within the E1 transmembrane domain. Taken together, these results indicate that a rearrangement of E1E2 heterodimer complexes likely occurs during the assembly of HCV particles to yield a trimeric form of the E1E2 heterodimer. Gaining structural information on this trimer will be helpful for the design of an anti-HCV vaccine.

Indexed as

Amino Acid MotifsBinding SitesEscherichia coliGene ExpressionHepacivirusModels, MolecularMolecular Sequence DataMutationProtein BindingProtein MultimerizationProtein StabilityProtein Structure, TertiaryRecombinant Fusion ProteinsSequence AlignmentViral Envelope ProteinsVirionE1 protein, Hepatitis C virusglycoprotein E2, Hepatitis C virusRecombinant Fusion ProteinsViral Envelope Proteins

Identifiers

PMID26246575
PMCPMC4580159
OpenAlexW1947712816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.